Switching genes, not sequences: the rise of epigenetic editing
Chemistry World - 09-Apr-2025Precision drugs use chemical tags to control genes without changing DNA
Join the club for FREE to access the whole archive and other member benefits.
Professor of Biomedical Engineering at Duke University
Dr. Charles Gersbach is the John W. Strohbehn Distinguished Professor of Biomedical Engineering and Director of the Center for Advanced Genomic Technologies at Duke University. His research interests are in genome and epigenome editing, gene therapy, regenerative medicine, biomolecular and cellular engineering, synthetic biology, and genomics. Dr. Gersbach’s work has been recognized through awards including the National Institutes of Health Director’s New Innovator Award, the National Science Foundation CAREER Award, the Outstanding New Investigator Award from the American Society of Gene and Cell Therapy, and induction into the American Institute for Medical and Biological Engineering and National Academy of Inventors.
Visit website: http://gersbach.bme.duke.edu/
See alsoDetails last updated 12-Nov-2023
Precision drugs use chemical tags to control genes without changing DNA
29-Nov-2023 to 30-Nov-2023
Longevity summit organised by Hevolution Foundation (Riyadh,Saudi Arabia)